Record stringlengths 1 197k |
|---|
<|newrecord|> nctId: NCT06350526 id: PULMHEMA briefTitle: Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-03-01 date: 2025-06-01 date: 2024-04-05 date: 2024-04-05 name: New Valley University class: OTHER briefSu... |
<|newrecord|> nctId: NCT06350513 id: NecmettinE briefTitle: The Effect of Animated Movies and Storybooks on Fear and Anxiety Levels in Children With Type 1 Diabetes overallStatus: NOT_YET_RECRUITING date: 2024-03-25 date: 2024-09-25 date: 2025-02-25 date: 2024-04-05 date: 2024-04-05 name: Selverhan Yurttutan class: OTH... |
<|newrecord|> nctId: NCT06350500 id: I-3858823 briefTitle: A Patient Navigation Program for Addressing Disparities in Breast Cancer Care overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2026-01-01 date: 2026-01-01 date: 2024-04-05 date: 2024-04-09 name: Roswell Park Cancer Institute class: OTHER briefSummary: T... |
<|newrecord|> nctId: NCT06350487 id: SMC2024-01-089-003 briefTitle: The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction acronym: ENRICH-PEF overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-12-31 date: 2026-06-30 date: 2024-04-05 date: 2024-04-08 name: Samsung Medical Center cla... |
<|newrecord|> nctId: NCT06350474 id: SIMPLIFY-IP-19 Dnase briefTitle: Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study acronym: SIMPLIFY-DN overallStatus: COMPLETED date: 2020-08-25 date: 2022-07-11 date: 2022-07-11 date: 2024-04-05 date: 2024-04-05 ... |
ETI is a combination CFTR modulator therapy that was approved by the Food and Drug Administration for people with CF who have at least one F508del mutation. The three drugs that make up ETI work together to allow many more chloride ions to move into and out of the cells, improving the balance of salt and water in the l... |
Dornase alfa (Dnase) also improves clearance of mucus from the lungs to support lung function and has been available to people with CF for many years. Dnase is considered to be relatively burdensome and it is not known whether Dnase can improve or maintain lung function above what is already gained through ETI use. |
The goal of this SIMPLIFY sub-study is to get information about whether or not it is safe to stop Dnase by testing if there is a change in lung function in participants with cystic fibrosis (CF) who are assigned to stop taking Dnase as compared to those who are assigned to keep taking Dnase while continuing to take ETI... |
This is a sub study of master protocol SIMPLIFY-IP-19, NCT04378153. |
The sub study investigating the impact of discontinuing and continuing hypertonic saline is registered under NCTXXXXXXX (will add once available). conditions: Cystic Fibrosis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: NONE count: 477 type: ACTU... |
<|newrecord|> nctId: NCT06350461 id: SIMPLIFY-IP-19 HS briefTitle: Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study acronym: SIMPLIFY-HS overallStatus: COMPLETED date: 2020-08-25 date: 2022-07-11 date: 2022-07-11 date: 2024-04-05 date: 2024-04-05 name... |
ETI is a combination CFTR modulator therapy that was approved by the Food and Drug Administration for people with CF who have at least one F508del mutation. The three drugs that make up ETI work together to allow many more chloride ions to move into and out of the cells, improving the balance of salt and water in the l... |
Inhaled hypertonic saline (HS) also improves clearance of mucus from the lungs to support lung function and has been available to people with CF for many years. HS is considered to be relatively burdensome and it is not known whether HS can improve or maintain lung function above what is already gained through ETI use. |
The goal of this SIMPLIFY sub-study is to get information about whether or not it is safe to stop hypertonic saline by testing if there is a change in lung function in participants with cystic fibrosis (CF) who are assigned to stop taking HS as compared to those who are assigned to keep taking HS while continuing to ta... |
This is a sub study of master protocol SIMPLIFY-IP-19, NCT04378153. |
The sub study investigating the impact of discontinuing and continuing dornase alfa is registered under NCTXXXXXXX (will add once available). conditions: Cystic Fibrosis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: NONE count: 370 type: ACTUAL na... |
<|newrecord|> nctId: NCT06350448 id: WMT-CN-RH briefTitle: Washed Microbiota Transplantation for Rhinitis overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2029-05-01 date: 2029-08-01 date: 2024-04-05 date: 2024-04-05 name: The Second Hospital of Nanjing Medical University class: OTHER briefSummary: The common s... |
<|newrecord|> nctId: NCT06350435 id: CUHK 2023.569 briefTitle: Effects of Prefabricated Foot Orthoses With and Without Metatarsal Pads on Central Metatarsalgia overallStatus: ACTIVE_NOT_RECRUITING date: 2023-12-18 date: 2024-04-26 date: 2024-05-31 date: 2024-04-05 date: 2024-04-05 name: Chinese University of Hong Kong ... |
<|newrecord|> nctId: NCT06350422 id: Microgravity-ChinaPLAGH briefTitle: Neuroimage Genome Study of Neuroplasticity Associated With Microgravity overallStatus: ACTIVE_NOT_RECRUITING date: 2022-01-01 date: 2024-10-31 date: 2024-12-31 date: 2024-04-05 date: 2024-04-05 name: Chinese PLA General Hospital class: OTHER brief... |
<|newrecord|> nctId: NCT06350409 id: CTN-0146 id: UG1DA015831-22S4 type: NIH link: https://reporter.nih.gov/quickSearch/UG1DA015831-22S4 briefTitle: Adolescent Outcomes of Post-operative Opioid EXposure acronym: APEX overallStatus: NOT_YET_RECRUITING date: 2024-08-10 date: 2026-09-10 date: 2026-10-10 date: 2024-04-05 d... |
<|newrecord|> nctId: NCT06350396 id: CPLTRDDM2024 briefTitle: pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-12-30 date: 2025-06-30 date: 2024-04-05 date: 2024-04-05 name: Changping Laboratory class: OTHER briefSummary: This study is a multicent... |
<|newrecord|> nctId: NCT06350383 id: K01TW011775 type: NIH link: https://reporter.nih.gov/quickSearch/K01TW011775 briefTitle: Adapting a Low-cost Intimate Partner Violence and Mental Health Response Intervention overallStatus: NOT_YET_RECRUITING date: 2024-05-06 date: 2025-01-06 date: 2025-01-06 date: 2024-04-05 date: ... |
<|newrecord|> nctId: NCT06350370 id: NCC3489 briefTitle: Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study overallStatus: RECRUITING date: 2019-01-01 date: 2023-01-01 date: 2028-01-01 date: 2024-04-05 date: 2024-04-05 name: ... |
<|newrecord|> nctId: NCT06350357 id: 2024B014 briefTitle: Conventional Clipping Versus Punching Closure overallStatus: RECRUITING date: 2024-04-01 date: 2025-12-31 date: 2025-12-31 date: 2024-04-05 date: 2024-04-05 name: Ningbo No. 1 Hospital class: OTHER briefSummary: Endoscopic submucosal dissection (ESD) is an impor... |
<|newrecord|> nctId: NCT06350344 id: HZKY-PJ-2024-8-2 briefTitle: Smart Technology Facilitated Patient-centered Venous Thromboembolism Management acronym: SmaVTE-COR overallStatus: NOT_YET_RECRUITING date: 2024-11-01 date: 2026-10-31 date: 2027-10-31 date: 2024-04-05 date: 2024-04-11 name: Navy General Hospital, Beijin... |
The objective of this study is to observe the long-term effect of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on thromboprophylaxis, and establish a foundation of evidence for managing patients with high-risk VTE. conditions: Venous Thromboembolism... |
<|newrecord|> nctId: NCT06350331 id: HZKY-PJ-2024-8-1 briefTitle: Smart Technology Facilitated Patient-centered Venous Thromboembolism Management acronym: SmaVTE-RCT overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2024-10-31 date: 2024-10-31 date: 2024-04-05 date: 2024-04-11 name: Navy General Hospital, Beijin... |
The objective of this study is to evaluate the impact of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on patients' perceptions of thromboprophylaxis, in order to enhance clinical practice and establish a foundation of evidence for managing patients ... |
<|newrecord|> nctId: NCT06350318 id: MCC-22005 briefTitle: Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas overallStatus: RECRUITING date: 2024-03-13 date: 2029-03 date: 2029-03 date: 2024-04-05 date: 2024-04-23 name: H. Lee Moffitt Cancer Center and Research Institute class: OTHER name: BeiGene, ... |
<|newrecord|> nctId: NCT06350305 id: Screening for high-risk COPD briefTitle: Screening for High-risk Chronic Obstructive Pulmonary Disease overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2027-04-30 date: 2027-10-31 date: 2024-04-05 date: 2024-04-11 name: Henan University of Traditional Chinese Medicine class:... |
<|newrecord|> nctId: NCT06350292 id: 0161464 briefTitle: SLEEP-COPE: Sleep Intervention for Oppositional Children overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-01-01 date: 2025-02-01 date: 2024-04-05 date: 2024-04-05 name: University of South Florida class: OTHER briefSummary: Children with Oppositional... |
<|newrecord|> nctId: NCT06350279 id: HSK39297-101 briefTitle: A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy Subjects overallStatus: RECRUITING date: 2023-12-25 date: 2024-05-31 date: 2024-07-31 date: 2024-04-05 date: 2024-04-05 name: Haisco Pharmaceutical Group Co., L... |
<|newrecord|> nctId: NCT06350266 id: 2024-0183 briefTitle: Informing Low-acuity Emergency Department Patients of Non-emergent Resources overallStatus: NOT_YET_RECRUITING date: 2024-04-22 date: 2024-12 date: 2024-12 date: 2024-04-05 date: 2024-04-05 name: Geisinger Clinic class: OTHER briefSummary: The goal of this camp... |
<|newrecord|> nctId: NCT06350253 id: 22-X-187 briefTitle: Comparison Of Measured To Predicted Resting Metabolism overallStatus: RECRUITING date: 2023-03-14 date: 2024-12-31 date: 2025-12-31 date: 2024-04-05 date: 2024-04-05 name: Ohio University class: OTHER briefSummary: The purpose of this study is to compare RMR val... |
<|newrecord|> nctId: NCT06350240 id: KUzunAkkaya briefTitle: Effects of Textured Insoles and Exercise in Children With Joint Hypermobility overallStatus: RECRUITING date: 2023-11-01 date: 2024-11-01 date: 2024-11-30 date: 2024-04-05 date: 2024-04-05 name: Gazi University class: OTHER name: TÜBİTAK briefSummary: Joint h... |
<|newrecord|> nctId: NCT06350227 id: WestChinaSU briefTitle: Impact of Different Hemostasis Methods on Ovarian Function and Fertility During Laparoscopic Ovarian Cystectomy of Benign Ovarian Cyst overallStatus: RECRUITING date: 2024-01-04 date: 2026-01 date: 2026-06 date: 2024-04-05 date: 2024-04-05 name: West China Se... |
<|newrecord|> nctId: NCT06350214 id: #2005-06; #2011-17; #2018-01 briefTitle: Physical Activity and Nutrition in Cancer Survivors overallStatus: COMPLETED date: 2007-01-01 date: 2018-12-31 date: 2018-12-31 date: 2024-04-05 date: 2024-04-05 name: West China Hospital class: OTHER briefSummary: This study aims to investig... |
<|newrecord|> nctId: NCT06350201 id: KY2024.0124.02 briefTitle: Machine Learning-based Classification of Symptom Clusters and Online CBT overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2024-12-01 date: 2024-12-01 date: 2024-04-05 date: 2024-04-09 name: Wuhan Mental Health Centre class: OTHER briefSummary: To b... |
<|newrecord|> nctId: NCT06350188 id: ECM#2024-506 briefTitle: Efficacy of Kinesiotape on Treatment of Nonspecific Cardiac Chest Pain overallStatus: ACTIVE_NOT_RECRUITING date: 2024-03-22 date: 2024-06-22 date: 2024-07-22 date: 2024-04-05 date: 2024-04-05 name: Cairo University class: OTHER briefSummary: purpose of the ... |
<|newrecord|> nctId: NCT06350175 id: 2212697123 briefTitle: Emergency Department Management of Tobacco Use Disorder overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-03 date: 2025-06 date: 2024-04-05 date: 2024-04-16 name: West Virginia University class: OTHER briefSummary: The objective of this study is to de... |
<|newrecord|> nctId: NCT06350162 id: ASTRUM-LC12 briefTitle: Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC overallStatus: RECRUITING date: 2023-10-18 date: 2024-12-31 date: 2025-12-31 date: 2024-04-05 date: 2024-04-05 name: Zhejiang Cancer Hospital class: OTHER briefSummary: This... |
<|newrecord|> nctId: NCT06350149 id: STUDY00004637 id: 1R21DK128731-01A1 type: NIH link: https://reporter.nih.gov/quickSearch/1R21DK128731-01A1 briefTitle: A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis overallStatus: R... |
* Whether conducting a randomized 2x2 factorial design that evaluates acute postprandial changes in glucose over 2 hours following ingestion of a mixed meal challenge that varies by glycemic index and consumption of a sugar-sweetened beverage is acceptable and feasible. |
* What are the preliminary changes in postprandial hyperglycemia, islet cell function, and incretin response to a high or low Glycemic Index mixed meal tolerance test (MMTT) with and without Sugar-Sweetened Beverages (SSB) in adolescents and young adults with CF |
Participants will be randomized to a mixed diet and blood will be drawn before and after the mixed meal challenge. conditions: Cystic Fibrosis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: FACTORIAL primaryPurpose: OTHER masking: NONE count: 40 type: ESTIMATED name: Sugar Sweetened Beve... |
<|newrecord|> nctId: NCT06350136 id: 2024/05-37 briefTitle: The Effect of Self-Management Support Provided to Hypertension Patients Affected by the Earthquake Via Tele-Nursing on Patients' Treatment Compliance and Self-Care Management overallStatus: NOT_YET_RECRUITING date: 2024-06-01 date: 2024-12-01 date: 2025-06-01 ... |
. The results obtained within this framework may provide guidance in the development and implementation of Turkey's health policies, and may also shed light on strategies for the management of other similar health problems. On the other hand, strengthening the digital health infrastructure and effective management of c... |
<|newrecord|> nctId: NCT06350123 id: D6405C00002 briefTitle: Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease. acronym: MIRO-CKD overallStatus: NOT_YET_RECRUITING date: 2024-05-06 date: 2026-01-13 date: 2026-01-13 date: 2024-04-05 date: 2024... |
<|newrecord|> nctId: NCT06350110 id: ESBI202492 briefTitle: Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) acronym: BAH242 overallStatus: NOT_YET_RECRUITING date: 2024-11-10 date: 2025-12-10 date: 2025-12-28 date: 2024-04-05 date: 2024-04-05 name: Essen Biotech class: OTHER... |
Patients enrolled in this clinical trial will receive a carefully designed treatment regimen. Prior to the infusion of CD19 and BCMA CAR-T cells, participants will undergo preconditioning chemotherapy. This chemotherapy serves to create an optimal environment for the CAR-T cell therapy to effectively target and elimina... |
Monitoring and Follow-up: |
Following the CAR-T cell infusion, patients will be subjected to rigorous monitoring to assess safety and treatment response. primaryPurpose: TREATMENT masking: NONE maskingDescription: Open-label clinical trials are a category of clinical research where the masking is minimal or nonexistent. In such trials, both the p... |
<|newrecord|> nctId: NCT06350097 id: D516NC00001 briefTitle: Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer acronym: TROPION-Lung14 overallStatus: NOT_YET_RECRUITING date: 2024-05-16 date: 2028-03-21 date: ... |
Study details include: |
1. The study duration will be event-driven, with an estimated duration of approximately 9 years. |
2. Participants may receive study treatment until disease progression, unacceptable toxicity, or other specific discontinuation criteria are met. |
3. The visit frequency will be every 3 weeks during the treatment period. |
Note: Participants on osimertinib treatment (osimertinib only arm or who have discontinued Datopotamab Deruxtecan while are still receiving osimertinib) are required to attend visits to perform assessments every 6 weeks from Cycle 7 until Cycle 17 and then visits every 12 weeks until disease progression, IP discontinua... |
<|newrecord|> nctId: NCT06350084 id: 2023/381 briefTitle: Effect of Mother's Touch and Nurse's Therapeutic Touch on Pain Level and Crying Time During Heel Blood Collection overallStatus: RECRUITING date: 2023-09-04 date: 2024-07-31 date: 2024-12-31 date: 2024-04-05 date: 2024-04-08 name: Burdur Mehmet Akif Ersoy Univer... |
<|newrecord|> nctId: NCT06350071 id: 2023/06 briefTitle: Effect of Kangaroo Care and Swaddling Methods on Pain Level and Crying Time During Heel Blood Collection overallStatus: RECRUITING date: 2023-06-19 date: 2024-07-31 date: 2024-12-31 date: 2024-04-05 date: 2024-04-08 name: Burdur Mehmet Akif Ersoy University class... |
<|newrecord|> nctId: NCT06350058 id: 202012005 briefTitle: Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old overallStatus: ACTIVE_NOT_RECRUITING date: 2021-08-03 date: 2023-11-30 date: 2024-10-31 date: 2024-04-05 date: 2024-04-05 name: Beijing Zhifei Lvzhu Biopharmaceuti... |
<|newrecord|> nctId: NCT06350045 id: supra 11th puncture PCNL briefTitle: High Supracostal Versus Subcostal Puncture in Adult PCNL overallStatus: ACTIVE_NOT_RECRUITING date: 2024-03-01 date: 2028-04-01 date: 2028-04-01 date: 2024-04-05 date: 2024-04-05 name: Assiut University class: OTHER briefSummary: as the supra ele... |
<|newrecord|> nctId: NCT06350032 id: TREPaed id: 2023-505082-91-00 type: CTIS briefTitle: Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2028-11 date: 2028-11 date: 2024-04-05 date: 2024-04-05 name: AOP Orpha... |
• if preservative-free parenteral treprostinil is safe and tolerable in the treatment of paediatric PAH in patients who are either treatment-naïve or have been previously treated with commercially available parenteral treprostinil formulations. |
Participants will receive either subcutaneous (SC) or intravenous (IV) preservative-free treprostinil and will be observed for 5 months (20 weeks ± 1 week). conditions: Pulmonary Arterial Hypertension studyType: INTERVENTIONAL phases: PHASE3 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT maski... |
<|newrecord|> nctId: NCT06350019 id: 26379996/91 briefTitle: Vascular Effects of Penil revascularızatıon overallStatus: COMPLETED date: 2013-01-01 date: 2014-08-15 date: 2014-12-25 date: 2024-04-05 date: 2024-04-05 name: Ankara Yildirim Beyazıt University class: OTHER briefSummary: Purpose: The aim of this study is to ... |
Methods: A total of 35 participants who underwent penile revascularization surgery due to vascular ED were included in this study. In the preoperative period and at the 3rd postoperative month, penile color doppler ultrasonography (PCDU) was performed to evaluate cavernosal arteries, dorsal arteries, deep dorsal vein a... |
<|newrecord|> nctId: NCT06350006 id: SHR-A1904-301 briefTitle: SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor overallStatus: RECRUITING date: 2024-05-30 date: 2027-12-30 date: 2028-12-30 date: 2024-04-05 date: 2024-04-26 name: Shanghai Hengrui Pharmaceutical Co., Ltd. class: INDUSTRY briefSummary: Thi... |
Phase Ib (includes dose escalation phase and efficacy extension phase): To explore the safety, tolerability and initial efficacy of SHR-A1904 in the treatment of CLDN18.2-positive advanced solid tumors, and to determine the recommended dose and recommended population for the Phase III combination study. |
Phase III: A randomized, double-blind, multicenter clinical study of SHR-1904 combined with chemotherapy and immunotherapy Versus chemotherapy combined with immunotherapy for CLDN18.2-positive advanced solid tumors. conditions: Cldn18.2-positive Advanced Solid Tumor studyType: INTERVENTIONAL phases: PHASE1 allocation: ... |
<|newrecord|> nctId: NCT06349993 id: pd003 briefTitle: Digital Intervention for Depression and Anxiety in Adolescents overallStatus: RECRUITING date: 2024-04-17 date: 2024-12-30 date: 2025-07-01 date: 2024-04-05 date: 2024-04-22 name: Adai Technology (Beijing) Co., Ltd. class: OTHER briefSummary: The goal of this clini... |
Participants will be asked to engage with the digital intervention platform for a period of two months. conditions: Depression conditions: Anxiety studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_... |
<|newrecord|> nctId: NCT06349980 id: HLX53-HCC201 briefTitle: A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 With or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. overallStatus: NOT_YET_RECRUITING date: 2024-... |
<|newrecord|> nctId: NCT06349967 id: WCH-2023-1592 briefTitle: Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer overallStatus: NOT_YET_RECRUITING date: 2024-04-30 date: 2027-04-30 date: 2027-05-30 date: 2024-04-05 date: 2024-04-05 name: West China Hospital class:... |
<|newrecord|> nctId: NCT06349954 id: BFHHZS20240064 briefTitle: Effectiveness and Safety of Single-session Endoscopic Stone Extraction overallStatus: RECRUITING date: 2024-04-15 date: 2024-12-01 date: 2024-12-01 date: 2024-04-05 date: 2024-04-18 name: Beijing Friendship Hospital class: OTHER briefSummary: This is a pro... |
<|newrecord|> nctId: NCT06349941 id: STU-2023-0745 briefTitle: Telemedicine in Rural Patients With Heart Failure acronym: RURAL-HF overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2024-12-01 date: 2024-12-01 date: 2024-04-05 date: 2024-04-05 name: University of Texas Southwestern Medical Center class: OTHER bri... |
<|newrecord|> nctId: NCT06349928 id: MASF_Dancers01 briefTitle: "The Show Must go on" : The Experience of Injuries Among Dancers: Fears, Thoughts, and Beliefs. A Qualitative Study overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-10-30 date: 2025-04-01 date: 2024-04-05 date: 2024-04-05 name: University of S... |
Dancers face a high risk of sustaining one or more injuries during their career (87-94%), which may lead to physical, psychological, and socioeconomic consequences affecting dancer's lives and careers both short and long-term. |
Dancers report fearing injury and its consequences and believing in the existence of a stigma around injury and injured colleagues; many of them also try to self-manage pain and delay reporting injuries to healthcare professionals, possibly making its outcomes worse. |
This study will collect data from dancers via focus groups and individual interviews, investigating dancers' experiences, thoughts, and beliefs about injury. Records from the interviews will be transcribed ad verbatim and analyzed using the framework method to synthetize the data and highlight the most meaningful conte... |
Understanding dancers' thoughts and behaviors regarding past or possible future injuries may be beneficial in improving treatment efficacy and designing adequate education and prevention strategies. It may also help raise awareness of dancers' complex and unique needs, and the importance of having accessible, specializ... |
<|newrecord|> nctId: NCT06349915 id: 2023-15217 briefTitle: A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents acronym: SWEEP overallStatus: NOT_YET_RECRUITING date: 2024-09 date: 2026-04 date: 2026-04 date: 2024-04-05 date: 2024-04-05 name: Albert Einstein College of Medicine class: OTH... |
<|newrecord|> nctId: NCT06349902 id: Pro00077561 briefTitle: Re-link HCV in Substance-Use Telemedicine Program overallStatus: RECRUITING date: 2024-03-12 date: 2024-08-31 date: 2024-12-31 date: 2024-04-05 date: 2024-04-05 name: trueNorth Medical Centres class: OTHER name: Gilead Sciences briefSummary: This is an observ... |
<|newrecord|> nctId: NCT06349889 id: MA-NPC-II-004 briefTitle: Adebrelimab and Chemoradiotherapy in High-risk Locoregionally Advanced Nasopharyngeal Carcinoma overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2028-05-01 date: 2028-05-01 date: 2024-04-05 date: 2024-04-09 name: Sun Yat-sen University class: OTHER ... |
<|newrecord|> nctId: NCT06349876 id: SUEZ MED - IRB Approval NO: 6 briefTitle: Cholecystectomy in Patients With Silent Common Bile Duct Stones overallStatus: COMPLETED date: 2023-02-15 date: 2023-07-15 date: 2024-01-15 date: 2024-04-05 date: 2024-04-23 name: Suez University class: OTHER briefSummary: Aim of this study ... |
<|newrecord|> nctId: NCT06349863 id: W23.225 briefTitle: Dutch CHolEcystitis Snapshot Study acronym: Dutch-CHESS overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-10-31 date: 2025-04-30 date: 2024-04-05 date: 2024-04-11 name: St. Antonius Hospital class: OTHER name: St. Antonius Onderzoeksfonds name: Dutch ... |
Purpose: To determine the variation in treatment of cholecystitis in the Netherlands and its impact on outcome. |
Methods: Nation-wide cohort study of all patients diagnosed and treated for cholecystitis during a 6 month period. The primary outcome will be the proportion of patients with an acute cholecystitis in which the guideline is followed. This group will be compared to those in which the guideline is not followed, focussing... |
Conclusion: This study will determine the variation in treatment of cholecystitis in the Netherlands and its impact on clinical outcome. Its results will serve as an important incentive to create optimal, uniform cholecystitis treatment in the Netherlands. conditions: Cholecystitis conditions: Cholecystitis; Gallstone ... |
<|newrecord|> nctId: NCT06349850 id: Soh-Med-24-03-06MS briefTitle: Predictive Value of Serum Uric Acid to High Density Lipoprotein Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-09 date: 2024-09 date: 2024-04-05 date: 2024-04-05 name: Sohag Un... |
<|newrecord|> nctId: NCT06349837 id: ECLIPSE-02 briefTitle: Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2025-03-31 date: 2026-03-31 date: 2024-04-05 date: 2024-04-05 name: Sichuan University class: O... |
<|newrecord|> nctId: NCT06349824 id: 004AEstb/EC/01/2022 briefTitle: Dextrose, Steroid, PRP: Choosing the Right Injection for CRS Relief; a RCT overallStatus: COMPLETED date: 2023-10-10 date: 2024-03-30 date: 2024-03-30 date: 2024-04-05 date: 2024-04-05 name: Sheikh Zayed Medical College class: OTHER_GOV briefSummary: ... |
<|newrecord|> nctId: NCT06349811 id: BL-M05D1-101 briefTitle: A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2026-05 date: 2026-05 date: 2024-04-05 date: 2024-04-09 name: Sichuan Baili Pharmaceutical Co., Ltd. class: INDUSTRY name: ... |
<|newrecord|> nctId: NCT06349798 id: DR200177 briefTitle: Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO) acronym: NEFARTHRO overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2026-09 date: 2027-04 date: 2024-04-05 date: 2024-04-05 name: University Hospital, Tours c... |
The primary endpoint is cumulative morphine consumption for the first postoperative 24 hours, expressed in mg of iv equivalent morphine, including titration in the Post Anesthesia Care Unit (PACU). |
Patients will be followed during 6 months. conditions: Total Hip Arthroplasty studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Multicenter, double-blind, randomized controlled trial in 3 parallel groups (placebo group, nefopam bolus group and nefo... |
<|newrecord|> nctId: NCT06349785 id: P.T.REC/012/003858 briefTitle: Manual Hyperinflation and Physical Therapy Program on Lung Recruitment Mechanically Ventilated Pediatric Patients acronym: MHI overallStatus: COMPLETED date: 2023-12-20 date: 2024-03-01 date: 2024-03-29 date: 2024-04-05 date: 2024-04-05 name: New Ismai... |
<|newrecord|> nctId: NCT06349772 id: FY2024-203 briefTitle: Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-04-01 date: 2025-04-01 date: 2024-04-05 date: 2024-04-08 name: Texas Tech University Health Sciences Ce... |
<|newrecord|> nctId: NCT06349759 id: OPI-NYXDLD-302 briefTitle: Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances acronym: LYNX-2 overallStatus: RECRUITING date: 2024-04-01 date: 2025-09 date: 2025-11 date: 2024-04-05 date: 2024-04-08 name: Ocuphi... |
<|newrecord|> nctId: NCT06349746 id: collage of physical therapy briefTitle: Cervical Unilateral Antero-posterior Mobilization and Thoracic Central Postro-anterior Mobilization in Treatment of Shoulder Impingement Syndrome overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2024-05 date: 2024-06 date: 2024-04-05 d... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.